Sharona Tornovsky-Babeay1,2, Noa Weinberg-Corem3, Rachel Ben-Haroush Schyr3, Dana Avrahami1,2,3, Judith Lavi1,2, Eseye Feleke1,2, Klaus H Kaestner4, Yuval Dor5, Benjamin Glaser6,7. 1. Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel. 2. Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. 3. Department of Developmental Biology and Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. 4. Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA. 5. Department of Developmental Biology and Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. yuvald@ekmd.huji.ac.il. 6. Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel. ben.glaser@mail.huji.ac.il. 7. Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. ben.glaser@mail.huji.ac.il.
Abstract
AIMS/HYPOTHESIS: Acute hyperglycaemia stimulates pancreatic beta cell proliferation in the mouse whereas chronic hyperglycaemia appears to be toxic. We hypothesise that this toxic effect is mediated by increased beta cell workload, unrelated to hyperglycaemia per se. METHODS: To test this hypothesis, we developed a novel mouse model of cell-autonomous increased beta cell glycolytic flux caused by a conditional heterozygous beta cell-specific mutation that activates glucokinase (GCK), mimicking key aspects of the rare human genetic disease GCK-congenital hyperinsulinism. RESULTS: In the mutant mice, we observed random and fasting hypoglycaemia (random 4.5-5.4 mmol/l and fasting 3.6 mmol/l) that persisted for 15 months. GCK activation led to increased beta cell proliferation as measured by Ki67 expression (2.7% vs 1.5%, mutant and wild-type (WT), respectively, p < 0.01) that resulted in a 62% increase in beta cell mass in young mice. However, by 8 months of age, mutant mice developed impaired glucose tolerance, which was associated with decreased absolute beta cell mass from 2.9 mg at 1.5 months to 1.8 mg at 8 months of age, with preservation of individual beta cell function. Impaired glucose tolerance was further exacerbated by a high-fat/high-sucrose diet (AUC 1796 vs 966 mmol/l × min, mutant and WT, respectively, p < 0.05). Activation of GCK was associated with an increased DNA damage response and an elevated expression of Chop, suggesting metabolic stress as a contributor to beta cell death. CONCLUSIONS/ INTERPRETATION: We propose that increased workload-driven biphasic beta cell dynamics contribute to decreased beta cell function observed in long-standing congenital hyperinsulinism and type 2 diabetes.
AIMS/HYPOTHESIS: Acute hyperglycaemia stimulates pancreatic beta cell proliferation in the mouse whereas chronic hyperglycaemia appears to be toxic. We hypothesise that this toxic effect is mediated by increased beta cell workload, unrelated to hyperglycaemia per se. METHODS: To test this hypothesis, we developed a novel mouse model of cell-autonomous increased beta cell glycolytic flux caused by a conditional heterozygous beta cell-specific mutation that activates glucokinase (GCK), mimicking key aspects of the rare human genetic disease GCK-congenital hyperinsulinism. RESULTS: In the mutant mice, we observed random and fasting hypoglycaemia (random 4.5-5.4 mmol/l and fasting 3.6 mmol/l) that persisted for 15 months. GCK activation led to increased beta cell proliferation as measured by Ki67 expression (2.7% vs 1.5%, mutant and wild-type (WT), respectively, p < 0.01) that resulted in a 62% increase in beta cell mass in young mice. However, by 8 months of age, mutant mice developed impaired glucose tolerance, which was associated with decreased absolute beta cell mass from 2.9 mg at 1.5 months to 1.8 mg at 8 months of age, with preservation of individual beta cell function. Impaired glucose tolerance was further exacerbated by a high-fat/high-sucrose diet (AUC 1796 vs 966 mmol/l × min, mutant and WT, respectively, p < 0.05). Activation of GCK was associated with an increased DNA damage response and an elevated expression of Chop, suggesting metabolic stress as a contributor to beta cell death. CONCLUSIONS/ INTERPRETATION: We propose that increased workload-driven biphasic beta cell dynamics contribute to decreased beta cell function observed in long-standing congenital hyperinsulinism and type 2 diabetes.
Authors: Sameer Kassem; Sonal Bhandari; Pablo Rodríguez-Bada; Roja Motaghedi; Maayan Heyman; M Adelaida García-Gimeno; Nadia Cobo-Vuilleumier; Pascual Sanz; Noel K Maclaren; Jacques Rahier; Benjamin Glaser; Antonio Luis Cuesta-Muñoz Journal: N Engl J Med Date: 2010-04-08 Impact factor: 91.245
Authors: Shay Porat; Noa Weinberg-Corem; Sharona Tornovsky-Babaey; Rachel Schyr-Ben-Haroush; Ayat Hija; Miri Stolovich-Rain; Daniela Dadon; Zvi Granot; Vered Ben-Hur; Peter White; Christophe A Girard; Rotem Karni; Klaus H Kaestner; Frances M Ashcroft; Mark A Magnuson; Ann Saada; Joseph Grimsby; Benjamin Glaser; Yuval Dor Journal: Cell Metab Date: 2011-04-06 Impact factor: 27.287
Authors: B Glaser; P Kesavan; M Heyman; E Davis; A Cuesta; A Buchs; C A Stanley; P S Thornton; M A Permutt; F M Matschinsky; K C Herold Journal: N Engl J Med Date: 1998-01-22 Impact factor: 91.245
Authors: H Kaneto; Y Kajimoto; Y Fujitani; T Matsuoka; K Sakamoto; M Matsuhisa; Y Yamasaki; M Hori Journal: Diabetologia Date: 1999-09 Impact factor: 10.122
Authors: Antonio L Cuesta-Muñoz; Hanna Huopio; Timo Otonkoski; Juan M Gomez-Zumaquero; Kirsti Näntö-Salonen; Jacques Rahier; Soledad López-Enriquez; Maria A García-Gimeno; Pascual Sanz; Federico C Soriguer; Markku Laakso Journal: Diabetes Date: 2004-08 Impact factor: 9.461